ACC/AHA 2008 guideline update on valvular heart disease: Focused update on infective endocarditis: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines: Endorsed by the society of cardiovascular anesthesiologists, society for cardiovascular angiography and interventions, and society of thoracic surgeons

Circulation

Volumn 118, Issue 8, 2008, Pages 887-896

  Nishimura, Rick A ^a   Carabello, Blase A ^a   Faxon, David P ^a   Freed, Michael D ^a   Lytle, Bruce W ^a   O'Gara, Patrick T ^a   O'Rourke, Robert A ^a   Shah, Pravin M ^a   Bonow, Robert O ^a   Chatterjee, Kanu ^a   De Leon Jr , Antonio C ^a   Gaasch, William H ^a   Otto, Catherine M ^a   Shanewise, Jack S ^a   Smith Jr , Sidney C ^a   Jacobs, Alice K ^a   Buller, Christopher E ^a   Creager, Mark A ^a   Ettinger, Steven M ^a   Krumholz, Harlan M ^a   Kushner, Frederick G ^a   Page, Richard L ^a   Tarkington, Lynn G ^a   Yancy Jr , Clyde W ^a   more..

^a NONE

Author keywords

ACC AHA practice guideline; Focused update; Infective endocarditis; Prophylaxis; Valvular heart disease

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFALEXIN; CEFAZOLIN; CEFTRIAXONE; CLARITHROMYCIN; CLINDAMYCIN; PENICILLIN DERIVATIVE;

ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; AORTA STENOSIS; BACTEREMIA; BACTERIAL ENDOCARDITIS; CLINICAL TRIAL; HIGH RISK PATIENT; HIGH RISK POPULATION; HUMAN; MEDICAL RESEARCH; MEDICAL SOCIETY; MEDICAL STAFF; MITRAL VALVE PROLAPSE; MITRAL VALVE REGURGITATION; MITRAL VALVE STENOSIS; ORGANIZATION AND MANAGEMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PULMONARY VALVE STENOSIS; REVIEW; RHEUMATIC FEVER; RISK FACTOR; TRANSLUMINAL VALVULOPLASTY; TREATMENT INDICATION; TRICUSPID VALVE REGURGITATION; URTICARIA; VALVULAR HEART DISEASE; ARTICLE; UNITED STATES;

AMERICAN HEART ASSOCIATION; ANTIBIOTIC PROPHYLAXIS; ENDOCARDITIS, BACTERIAL; HEART VALVE DISEASES; HUMANS; UNITED STATES;

EID: 53749101580     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.190377     Document Type: Review

References (9)

1. ACC/AHA Task Force on Practice Guidelines. Manual for ACC/AHA Guideline Writing Committees: Methodologies and Policies from the ACC/AHA Task Force on Practice Guidelines. Available at: http://www.acc.org/qualityandscience/ clinical/manual/pdfs/methodology.pdf and http://circ.ahajournals.org/manual/. Accessed June 2007.
2. Bonow RO, Carabello BA, Chatterjee K, et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Valvular Heart Disease). J Am Coll Cardiol. 2008. In press.
3. Bonow RO, Carabello BA, Chatterjee K, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2006;48:el-148.
4. Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2007;116:1736-54.
5. Baddour LM, Bettmann MA, Boiger AF, et al. Nonvalvular cardiovascular device-related infections. Circulation. 2003;108:2015-31.
6. Dajani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. Circulation. 1997;96:358-66.
7. Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation. 2005;lll:e394-434.
8. Horstkotte D, Follath F, Gutschik E, et al. Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European Society of Cardiology. Eur Heart J. 2004;25:267-76.
9. Gould FK, Elliott TS, Foweraker J, et al. Guidelines for the prevention of endocarditis: report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother. 2006;57:1035-42.